OMA to Exhibit at Mobile World Congress Shanghai 2015
Anonymousgraduapp.com
Shares of Synlogic (NASDAQ: SYBX ) moved higher by 10.11% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 7.69% year over year to ($0.36), which beat the estimate of ($0.47). Revenue of $0 decreased by 100.00% year over year, which missed the estimate of $280,000. Looking Ahead Earnings guidance hasnt been issued by the company for now. Revenue guidance hasnt been issued by the company for now. Details Of The Call Date: Nov 05, 2020 View more earnings on SYBX Time: 08:30 AM ET Webcast URL: https://edge.media-server.com/mmc/p/5yiybtxn Recent Stock Performance Companys 52-week high was at $3.46 52-week low: $1.35 Price action over last quarter: down 2.79% Company Profile Synlogic Inc is a biopharmaceutical company focused on advancing the drug discovery and development platform for Synthetic Biotic medicines, which are designed using synthetic biology to genetically reprogram beneficial microbes to treat metabolic and inflammatory diseases and cancer. See more from Benzinga Click here for options trades from Benzinga 12 Healthcare Stocks Moving In Wednesdays After-Market Session © 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View comments
Empowering Product Teams: A Shift in Leadership Dynamics
Explore how empowering product teams transforms leadership and drives innovation in today's business landscape.